Welcome to MS Views and News blog

MS Views and News, empowers those affected by Multiple Sclerosis (MS) with educational information, resources and services. Please scroll downward to find articles or videos of interest, then click to open the document or video.

Categories

Latest Blog Posts

February 28, 2023

ACTRIMS 2023: Loss of myelin in spinal cord tied to MS disability

  • MS Research Study and Reports
    /
 More loss in cervical region also linked to worse motor function by Lindsey Shapiro, PhD | February 27, 2023 A…
MS Research Study and Reports

February 28, 2023

MS and Concussions

  • Additional MS resource sites
    /
  • MS Research Study and Reports
    /
  MS and Concussions The exact cause of MS isn’t known, although experts believe that a number of things play…
Additional MS resource sites

February 28, 2023

‘Usual Suspect’ Lesions Appear Not to Cause Most Severe Disability in Multiple Sclerosis Patients

  • MS Research Study and Reports
    /
Presented at 2023 ACTRIMS in San Diego, Ca  Summary: While brain lesions may be a key marker for Multiple Sclerosis, they…
MS Research Study and Reports

February 28, 2023

Study helps make clear distinctions between MS, MOGAD (Myelin oligodendrocyte glycoprotein antibody-associated disease)

  • MS Research Study and Reports
    /
  • Other Neuro Conditions
    /
 February 25, 2023 The study was presented at the 2023 #ACTRIMS forum A new study set out to assess potentially…
MS Research Study and Reports

February 28, 2023

Lower-dose gadolinium now being used for MRIs with contrast

  • Marketing
    /
 by Ed Tobias | February 24, 2023 If you have multiple sclerosis (MS), I’m sure you’ve had several MRIs by now. You’ve probably also…
Marketing

February 28, 2023

Favorable Safety Outcomes Observed in Ozanimod (#Zeposia) Over Diroximel Fumarate (Vumerity)

  • MS Drug Therapies
    /
  • MS Research Study and Reports
    /
 Feb 26, 2023 – Marco Meglio        – #ACTRIMS Conferences: Americas Committee for Treatment and Research in Multiple Sclerosis…
MS Drug Therapies

February 27, 2023

Patients With NMOSD ( neuromyelitis optica spectrum disorder ) Relapse Events Experience High Economic Burden

  • NMO (NMOSD/Devics)
    /
 #ACTRIMS                #NMOSD Feb 27, 2023          Isabella Ciccone, MPH A…
NMO (NMOSD/Devics)

February 27, 2023

Metabolic Changes, Cognitive Improvements in Multiple Sclerosis Observed Through Intermittent Calorie Restriction

  • MS Research Study and Reports
    /
 Feb 27, 2023 –   Marco Meglio Compared with those on an unrestricted diet, patients with MS on intermittent calorie restriction…
MS Research Study and Reports

February 27, 2023

Gauging MS Disease Activity Through Octave’s MSDA Test

  • MS Research Study and Reports
    /
  • Multiple Sclerosis
    /
 Feb 24, 2023    Taylor Gonyou, DO The multiple sclerosis fellow at Michigan Institute for Neurologic Disorders provided perspective on…
MS Research Study and Reports

February 27, 2023

BTK Inhibitor Evobrutinib Displays Superior Efficacy Compared With Anti-CD20 Treatment for MS

  • MS Drug Therapies
    /
  • MS Research Study and Reports
    /
 Feb 25, 2023 – Isabella Ciccone, MPH A preclinical assessment of evobrutinib showed it demonstrated superior efficacy in targeting compartmentalized…
MS Drug Therapies

Categories

Latest Blog Posts